NASDAQ:TMCI Treace Medical Concepts (TMCI) Stock Price, News & Analysis → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free TMCI Stock Alerts $13.05 +0.69 (+5.58%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$12.41▼$13.2050-Day Range$11.48▼$15.8652-Week Range$5.27▼$27.97Volume345,502 shsAverage Volume524,016 shsMarket Capitalization$805.97 millionP/E RatioN/ADividend YieldN/APrice Target$19.58 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Treace Medical Concepts alerts: Email Address Treace Medical Concepts MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.83 Rating ScoreUpside/Downside49.4% Upside$19.58 Price TargetShort InterestBearish6.79% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.63Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.91) to ($0.79) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.56 out of 5 starsMedical Sector651st out of 938 stocksSurgical & Medical Instruments Industry65th out of 97 stocks 3.4 Analyst's Opinion Consensus RatingTreace Medical Concepts has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $19.58, Treace Medical Concepts has a forecasted upside of 49.4% from its current price of $13.11.Amount of Analyst CoverageTreace Medical Concepts has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted6.79% of the float of Treace Medical Concepts has been sold short.Short Interest Ratio / Days to CoverTreace Medical Concepts has a short interest ratio ("days to cover") of 5.6.Change versus previous monthShort interest in Treace Medical Concepts has recently decreased by 2.33%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldTreace Medical Concepts does not currently pay a dividend.Dividend GrowthTreace Medical Concepts does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TMCI. Previous Next 2.6 News and Social Media Coverage News SentimentTreace Medical Concepts has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Treace Medical Concepts this week, compared to 2 articles on an average week.MarketBeat Follows2 people have added Treace Medical Concepts to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Treace Medical Concepts insiders have not sold or bought any company stock.Percentage Held by Insiders28.69% of the stock of Treace Medical Concepts is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions84.08% of the stock of Treace Medical Concepts is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Treace Medical Concepts are expected to grow in the coming year, from ($0.91) to ($0.79) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Treace Medical Concepts is -16.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Treace Medical Concepts is -16.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTreace Medical Concepts has a P/B Ratio of 5.85. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIBuy Friday, Sell Monday, No Exceptions Every week traders grind it out Monday through Friday… But neglect trading Friday to Monday… Or… “over the weekend” As one professional trader explains, trading over the weekend is one of the most forgiving strategies you can use today. It allows him to sidestep a lot of the midweek volatility. Yet, gives him the opportunity to target some of the markets biggest stock moves. Just recently, he posted a trade on Nordstrom… The trade was published at 3pm on a Friday afternoon and by Monday morning the trade more than doubled.And for the first time in 2024, he’s sharing his strategy for free. About Treace Medical Concepts Stock (NASDAQ:TMCI)Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.Read More TMCI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TMCI Stock News HeadlinesMarch 25, 2024 | globenewswire.comTreace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient MilestoneMarch 1, 2024 | seekingalpha.comTreace Medical Concepts Inc (TMCI) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | Crypto 101 Media (Ad)Major Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.March 1, 2024 | finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported And Analysts Have Been Lifting Their Price TargetsMarch 1, 2024 | morningstar.comTreace Medical Concepts IncFebruary 29, 2024 | finance.yahoo.comTreace Medical Concepts Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 29, 2024 | finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2023 Earnings Call TranscriptFebruary 28, 2024 | markets.businessinsider.comBuy Rating on Treace Medical Concepts: Promising Financial Outlook and Strategic Product Innovation Drive GrowthMarch 28, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionFebruary 27, 2024 | finance.yahoo.comTreace Medical Concepts Inc (TMCI) Reports Robust Revenue Growth and Expands Surgeon Base in Q4 ...February 27, 2024 | globenewswire.comTreace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 GuidanceFebruary 20, 2024 | msn.comGlobus Medical (GMED) Q4 Earnings and Revenues Beat EstimatesFebruary 20, 2024 | finance.yahoo.comEarnings Preview: Treace Medical Concepts (TMCI) Q4 Earnings Expected to DeclineFebruary 20, 2024 | finance.yahoo.comTMCI Sep 2024 20.000 callFebruary 20, 2024 | finance.yahoo.comTMCI Jun 2024 22.500 callFebruary 18, 2024 | finance.yahoo.comTMCI Mar 2024 17.500 callFebruary 17, 2024 | finance.yahoo.comTMCI Mar 2024 25.000 callFebruary 13, 2024 | uk.investing.comTreace Medical Concepts Inc (TMCI)February 7, 2024 | finance.yahoo.comTreace to Report Fourth Quarter and Full-Year 2023 Financial ResultsFebruary 2, 2024 | finance.yahoo.comTreace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® ProcedureFebruary 1, 2024 | finance.yahoo.comTreace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific ConferenceJanuary 31, 2024 | markets.businessinsider.comTruist Financial Sticks to Their Buy Rating for Treace Medical Concepts (TMCI)January 8, 2024 | msn.comTreace Medical forecasts upbeat Q4, 2023 revenue outlookJanuary 8, 2024 | finance.yahoo.comTreace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 RevenueDecember 31, 2023 | markets.businessinsider.comBTIG Reaffirms Their Buy Rating on Treace Medical Concepts (TMCI)December 28, 2023 | benzinga.comTreace Medical Concepts Stock (NASDAQ:TMCI), Quotes and News SummaryDecember 27, 2023 | benzinga.comTreace Medical Concepts Stock (NASDAQ:TMCI), Short Interest ReportSee More Headlines Receive TMCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Treace Medical Concepts and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today3/28/2024Next Earnings (Estimated)5/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:TMCI CUSIPN/A CIK1630627 Webwww.treace.com Phone904-373-5940FaxN/AEmployees516Year FoundedN/APrice Target and Rating Average Stock Price Target$19.58 High Stock Price Target$27.50 Low Stock Price Target$11.00 Potential Upside/Downside+50.1%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-49,530,000.00 Net Margins-26.47% Pretax Margin-26.47% Return on Equity-33.96% Return on Assets-19.99% Debt Debt-to-Equity Ratio0.38 Current Ratio4.40 Quick Ratio3.76 Sales & Book Value Annual Sales$187.12 million Price / Sales4.31 Cash FlowN/A Price / Cash FlowN/A Book Value$2.24 per share Price / Book5.83Miscellaneous Outstanding Shares61,760,000Free Float44,037,000Market Cap$805.97 million OptionableOptionable Beta0.28 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. John T. Treace (Age 52)CEO, Founder & Director Comp: $1.04MMr. Mark L. Hair CPA (Age 54)Chief Financial Officer Comp: $628.6kMr. Aaron J. Berutti (Age 45)Senior Vice President of Sales Comp: $519.41kMr. Terry W. Lubben (Age 59)Senior Vice President of Operations Ms. Julie D. Dewey (Age 63)Chief Communications & Investor Relations Officer Mr. Scot M. Elder (Age 49)Chief Legal & Compliance Officer and Corporate Secretary Mr. Nathan MinnichSenior Vice President of MarketingMr. Daniel E. Owens (Age 52)Chief Human Resources Officer Dr. Sean F. Scanlan Ph.D. (Age 41)Chief Innovation Officer Ms. Shana ZinkSenior Vice President of Clinical Affairs, Medical Education & ReimbursementMore ExecutivesKey CompetitorsEmbectaNASDAQ:EMBCSilk Road MedicalNASDAQ:SILKAtrionNASDAQ:ATRISI-BONENASDAQ:SIBNOrthoPediatricsNASDAQ:KIDSView All CompetitorsInsiders & InstitutionsNewbridge Financial Services Group Inc.Bought 3,567 shares on 3/28/2024Ownership: 0.012%Vanguard Group Inc.Bought 104,207 shares on 3/11/2024Ownership: 6.952%Perceptive Advisors LLCSold 583,655 shares on 2/26/2024Ownership: 2.027%GSA Capital Partners LLPBought 78,591 shares on 2/16/2024Ownership: 0.127%Price T Rowe Associates Inc. MDBought 1,107 shares on 2/16/2024Ownership: 0.019%View All Insider TransactionsView All Institutional Transactions TMCI Stock Analysis - Frequently Asked Questions Should I buy or sell Treace Medical Concepts stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Treace Medical Concepts in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TMCI shares. View TMCI analyst ratings or view top-rated stocks. What is Treace Medical Concepts' stock price target for 2024? 6 brokerages have issued 12 month price targets for Treace Medical Concepts' shares. Their TMCI share price targets range from $11.00 to $27.50. On average, they predict the company's stock price to reach $19.58 in the next twelve months. This suggests a possible upside of 49.4% from the stock's current price. View analysts price targets for TMCI or view top-rated stocks among Wall Street analysts. How have TMCI shares performed in 2024? Treace Medical Concepts' stock was trading at $12.75 at the beginning of the year. Since then, TMCI stock has increased by 2.8% and is now trading at $13.11. View the best growth stocks for 2024 here. When is Treace Medical Concepts' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our TMCI earnings forecast. How were Treace Medical Concepts' earnings last quarter? Treace Medical Concepts, Inc. (NASDAQ:TMCI) released its quarterly earnings results on Tuesday, February, 27th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.09) by $0.01. The firm earned $62.20 million during the quarter, compared to analysts' expectations of $60.56 million. Treace Medical Concepts had a negative trailing twelve-month return on equity of 33.96% and a negative net margin of 26.47%. The business's revenue was up 24.9% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.08) earnings per share. What guidance has Treace Medical Concepts issued on next quarter's earnings? Treace Medical Concepts updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $220.0 million-$225.0 million, compared to the consensus revenue estimate of $223.2 million. When did Treace Medical Concepts IPO? Treace Medical Concepts (TMCI) raised $150 million in an initial public offering (IPO) on Friday, April 23rd 2021. The company issued 9,400,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. Who are Treace Medical Concepts' major shareholders? Treace Medical Concepts' stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.96%), Vanguard Group Inc. (6.95%), Armistice Capital LLC (4.63%), TimesSquare Capital Management LLC (2.84%), CIBC Private Wealth Group LLC (2.37%) and Perceptive Advisors LLC (2.03%). Insiders that own company stock include Aaron Berutti, Daniel E Owens, F Barry Bays, Jaime A Frias, James T Treace, John R Treace, John T Treace, Mark Hair, Richard W Mott, Scot Michael Elder, Sean F Scanlan, Terry W Lubben and Thomas E Timbie. View institutional ownership trends. How do I buy shares of Treace Medical Concepts? Shares of TMCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TMCI) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.